SVB Leerink is a Boston, Massachusetts based investment bank. They specialize in healthcare and life sciences with the experience and knowledge to help its clients to define and achieve their strategic, capital market and ivnestment objectives. SVB Leerink partners with companies that develop and commercialize innovative products and services in healthcare.
SVB Leerink has invested in and helped raise money on capital markets for 89Bio, affimed, CentoGene, Evolus, Innate Pharma, Principia Biopharma, Biontech, ProventionBio, Translate, Satsuma Pharmaceuticals and Fate Therapeutics.
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.
Dan Dubin, M.D.
Jeffrey A. Leerink
Chief Executive Officer
President Head of Investment Banking
John L. Sullivan, CFA
Senior Managing Director
Chief Administrative Officer
Managing Director, Human Resources
Senior Managing Director, Head of Institutional Equities
Senior Managing Director, General Counsel